The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma
Modern Pathology · 2023-10 · 36 (10) · 100274
DOI: 10.1016/j.modpat.2023.100274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2023-10. Verfasst von Kaori Ueda und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Maxillofa…. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Trans-Activators, Gene Rearrangement, Salivary Gland Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Nagoya City University, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Approximately 60% of adenoid cystic carcinoma (AdCC) cases are positive for MYB::NFIB or MYBL1::NFIB, whereas MYB/MYBL1 oncoprotein, a key driver of AdCC, is overexpressed in most cases. Juxtaposition of superenhancer regions in NFIB and other genes into the MYB/MYBL1 locus is an attractive oncogenic hypothesis for AdCC cases, either negative or positive for MYB/MYBL1::NFIB. However, evidence supporting this hypothesis is insufficient. We examined 160 salivary AdCC cases for rearrangements in MYB/MYBL1 loci and peri-MYB/MYBL1 areas (centromeric and telomeric areas of 10 Mb each) using formalin-fixed, paraffin-embedded tumor sections. For the detection of the rearrangements, we employed conventional fluorescence in situ hybridization split and fusion assays and a 5 Mb fluorescence in situ hybridization split assay. The latter is a novel assay that enabled us to detect any possible splits within a 5 Mb distance of a chromosome. We found MYB/MYBL1- and peri-MYB/MYBL1-associated rearrangements in 149/160 patients (93%). AdCC cases positive for rearrangements in MYB, MYBL1, the peri-MYB area, and the peri-MYBL1 area numbered 105 (66%), 20 (13%), 19 (12%), and 5 (3%), respectively. In 24 peri-MYB/MYBL1 rearrangement-positive cases, 14 (58%) were found to have a juxtaposition of the NFIB or RAD51B locus into the MYB/MYBL1 loci. On comparing with a tumor group positive for MYB::NFIB, a hallmark of AdCC, other genetically classified tumor groups had similar features of overexpression of the MYB transcript and MYB oncoprotein as detected by semiquantitative RT-qPCR and immunohistochemistry, respectively. In addition, clinicopathological and prognostic features were similar among these groups. Our study suggests that peri-MYB/MYBL1 rearrangements may be a frequent event in AdCC and may result in biological and clinicopathological consequences comparable to MYB/MYBL1 rearrangements. The landscape of MYB/MYBL1 and peri-MYB/MYBL1 rearrangements shown here strongly suggests that juxtaposition of superenhancers into MYB/MYBL1 or peri-MYB/MYBL1 loci is an alteration that acts as a key driver for AdCC oncogenesis and may unify MYB/MYBL1 rearrangement-positive and negative cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University, Nagoya, Ja…
- Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
- Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
- Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Förderung
- Nagoya City University
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Ueda, K., Murase, T., Kawakita, D., Nagao, T., Kusafuka, K., Nakaguro, M., Urano, M., Yamamoto, H., Taguchi, K. I., Kano, S., Tada, Y., Tsukahara, K., Okami, K., Onitsuka, T., Fujimoto, Y., Sakurai, K., Hanai, N., Nagao, T., Kawata, R., …, & Inagaki, H. (2023). The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma. Modern Pathology, 36(10), 100274. https://doi.org/10.1016/j.modpat.2023.100274
Vancouver
Ueda K, Murase T, Kawakita D, Nagao T, Kusafuka K, Nakaguro M, et al. The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma. Modern Pathology. 2023;36(10):100274. doi:10.1016/j.modpat.2023.100274
BibTeX
@article{Ueda2023,
author = {Ueda, Kaori and Murase, Takayuki and Kawakita, Daisuke and Nagao, Toshitaka and Kusafuka, Kimihide and Nakaguro, Masato and Urano, Makoto and Yamamoto, Hidetaka and Taguchi, Ken-Ichi and Kano, Satoshi and Tada, Yuichiro and Tsukahara, Kiyoaki and Okami, Kenji and Onitsuka, Tetsuro and Fujimoto, Yasushi and Sakurai, Kazuo and Hanai, Nobuhiro and Nagao, Toru and Kawata, Ryo and Hato, Naohito and Nibu, Ken-Ichi and Inagaki, Hiroshi},
title = {The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma},
journal = {Modern Pathology},
year = {2023},
volume = {36},
number = {10},
pages = {100274},
doi = {10.1016/j.modpat.2023.100274}
}
EUVIMED